BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jensen CM, Holle LM. Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection. Pharmacotherapy. 2016;36:562-574. [PMID: 27027412 DOI: 10.1002/phar.1748] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Schwarzman G, Rybalko D, Danilkowicz R, Hutchinson M. Revisiting Orthopaedic Surgery Residents' Views of the CDC and AAOS Precautionary Guidelines for HIV. JB JS Open Access 2018;3:e0022. [PMID: 30882055 DOI: 10.2106/JBJS.OA.18.00022] [Reference Citation Analysis]
2 Lu J, Zhang L, Xu X, Chen Y, Zhou Y, Zhang Z, Fu G, Chen G. Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China. Drug Alcohol Depend 2019;194:101-6. [PMID: 30419403 DOI: 10.1016/j.drugalcdep.2018.09.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lee HW, Yoo KY, Won JW, Kim HJ. Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced. Gut Liver 2017;11:721-7. [PMID: 28874040 DOI: 10.5009/gnl17209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ansari U, Henderson LI, Stott G, Parr K. Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus. JAAD Case Rep. 2017;3:67-69. [PMID: 28229123 DOI: 10.1016/j.jdcr.2016.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Taherkhani R, Farshadpour F. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World J Hepatol 2017; 9(33): 1239-1252 [PMID: 29312527 DOI: 10.4254/wjh.v9.i33.1239] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
6 Latini A, Orsini D, Ambrifi M, Colafigli M, Zaccarelli M, Cristaudo A. Classical Kaposi's sarcoma concurrent with ledipasvir-sofosbuvir therapy for hepatitis C infection. G Ital Dermatol Venereol 2019;154:593-4. [PMID: 29192474 DOI: 10.23736/S0392-0488.17.05788-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Johnson RJ, Shimada M. Contemporary Management of Hepatitis C in Patients with CKD. Clin J Am Soc Nephrol 2017;12:1563-5. [PMID: 28882856 DOI: 10.2215/CJN.07620717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
8 Al Khayat MNMT, Eijsink JFH, Postma MJ, Wilschut JC, van Hulst M. The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands. Int J Environ Res Public Health 2020;17:E6091. [PMID: 32825680 DOI: 10.3390/ijerph17176091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Alkaaby BA, Al-Ethawi AE. The effectiveness of oral antiviral (Sofosbuvir/Ledipasvir) in treating children with HCV infection. Pak J Med Sci. 2018;34:1353-1356. [PMID: 30559784 DOI: 10.12669/pjms.346.15722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]